Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.
about
Novel delivery system for natural products: Nano-curcumin formulationsFocus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic SystemsRecent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsNatural product-based nanomedicine: recent advances and issuesRegulating miRNA by natural agents as a new strategy for cancer treatmentLiposomal Antioxidants for Protection against Oxidant-Induced DamageEfficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat modelIn vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsionsSelective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin AnalogsTherapeutic applications of curcumin for patients with pancreatic cancer.Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.Curcumin and cancer: barriers to obtaining a health claim.Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malariaPerspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcuminFormation of curcumin nanoparticles via solution-enhanced dispersion by supercritical CO2.Formation and signaling actions of electrophilic lipidsSilica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcuminCurcumin: a natural substance with potential efficacy in Alzheimer's disease.Comparison of the colloidal stability, bioaccessibility and antioxidant activity of corn protein hydrolysate and sodium caseinate stabilized curcumin nanoparticles.Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study.Bioavailability of polyphenol liposomes: a challenge aheadDevelopment and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin.Plant Food Residues as a Source of Nutraceuticals and Functional Foods.Emerging technologies for improving phytochemical bioavailability: benefits and risks.Challenges associated with curcumin therapy in Alzheimer disease.Advances in nanotechnology-based delivery systems for curcumin.Encapsulation in a natural, preformed, multi-component and complex capsule: yeast cells.Encapsulation of natural polyphenolic compounds; a review.Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice.Potential bioavailability enhancement of bioactive compounds using food-grade engineered nanomaterials: a review of the existing evidence.Dietary factors affecting polyphenol bioavailability.Nanocarrier: a potential tool for future antioxidant therapy.Recent advances in curcumin nanoformulation for cancer therapy.Maintaining antioxidant potential of fresh fruits and vegetables after harvest.Delivery aspects of antioxidants in diabetes management.Natural product-based amyloid inhibitors.
P2860
Q26741732-7AF670EB-7B99-4396-A3B0-A73E9E26266DQ26767267-7A9E641A-5ADB-4DC9-A0A7-A6A9EF99B2BAQ26775886-ED6AD0F5-1024-45A6-AFEF-502B1E13B588Q26785633-4094CC96-93E4-4846-A995-427D4BE71893Q27026972-C4BA6C0D-D916-44A9-9F90-DD5D1A81F36DQ28391211-37263599-7A29-4194-A44B-5F1024CAA53BQ28534377-470142D1-857D-44D6-94F3-C73542298BEEQ30469832-6731B7FC-264D-4FB0-A70A-71FF087AA42CQ33683394-8F335948-D3CC-44A3-83F1-C3DEA30BAD55Q33948351-24BEEA07-72FF-41AA-886A-610D33C9FCD9Q34252516-90B3C28B-6A94-4E23-BB53-5893383E3254Q34283589-BC927169-EB4D-4E8C-893E-0FC2169BAC82Q34478532-C0D228B9-D1E2-4153-BBB4-1E243D46BB3BQ34629387-E75B2665-9A47-438A-B836-D5C430A2526EQ34687796-2BFB7BA5-5DF3-4D27-BB7C-40303125C03CQ34885283-246A8D43-1DF3-43E1-A012-F6AB1B594FD0Q34976272-6D036F90-04B1-4854-85B9-1A4767372BDDQ35298265-A5621B45-C537-4FC9-9B27-54F99474794AQ35586477-312CE147-912B-4E47-8C52-312A7E5F4053Q35804051-67652440-6349-43F1-BA7F-ABDE0E27AA7EQ36458029-DA40A7EA-9878-413E-B0F4-D1259C968246Q36891064-173DBB1F-729C-48B9-8F57-6BE41E81E4A0Q37313927-B8E781AA-413A-4A21-9787-D015D443CD2CQ37329522-013F3952-049D-45A0-8F66-2E4C8B1C5C17Q37332632-C7CC4E97-1D2E-42EC-9664-12C913702EDDQ37416747-168E8099-8BF0-40C4-9D2D-93D74207FB58Q37636137-89DA0D7A-AA3F-464A-882A-76D80963FA32Q37872194-BC96C84F-EBD7-424F-ADFB-8ADB83928951Q37952439-549F38F9-B72F-47B0-8DB5-693E1BDFCA87Q38030643-E2E01A00-A4DC-4459-92D4-261DE161C9C3Q38118860-F0B10303-62DF-4B55-B6E2-4EA8C1DDEE1EQ38168994-DB1CACF4-D84B-460B-B1D6-2B42956E854DQ38187406-09A49C4D-40CD-4055-BA82-A21EE8F5AB74Q38206137-134A1D04-A313-4BA1-A2A2-1F3C0D792493Q38211784-D913C82D-11A6-4B4C-A6AD-E3A9184B3191Q38213492-AD151BD5-BC23-4D84-A8AD-F334D37D3069Q38214381-B6743C17-A1D1-4886-914A-216854AF04EBQ38219131-511B2C1C-FC93-47F3-AE5D-8ED889FE17D3Q38315902-E4D2D798-4828-49A7-8964-A45E2D3DACD1Q38733078-85D9AEF5-85EA-4AA0-A694-2F2B3208ACB1
P2860
Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@en
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@nl
type
label
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@en
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@nl
prefLabel
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@en
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@nl
P2093
P356
P1476
Evaluation of an oral carrier ...... iposome-encapsulated curcumin.
@en
P2093
Kensaku Takara
Makoto Takahashi
Shuntoku Uechi
P304
P356
10.1021/JF9013923
P407
P577
2009-10-01T00:00:00Z